Hojo-Souza NS, de Castro JT, Rivelli GG, Azevedo PO, et al. SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine 2024;42:126394.
PMID: 39368129